Clinical Trial Update: Safety of Testosterone Undecanoate i.m. in Hypogonadal Men [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety of intramuscular testosterone undecanoate in men with hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• testosterone undecanoate (testosterone undecanoate)

Snippet

Sponsor: University Hospital Muenster | Conditions: Hypogonadism | Phase 2 | Status: COMPLETED